Jindal SAW Intrinsic Value
JINDALSAW • Industrial Products
Current Stock Price
₹183.12
Primary Intrinsic Value
₹114.24
Market Cap
₹1172 Cr
+100.0%
Upside
Median Value
₹366.24
Value Range
₹61 - ₹549
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
JINDALSAW Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹114.24 | ₹91.39 - ₹137.09 | -37.6% | EPS: ₹9.52, Sector P/E: 12x |
| Book Value Method | asset | ₹457.80 | ₹412.02 - ₹503.58 | +150.0% | Book Value/Share: ₹1711.56, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹366.24 | ₹329.62 - ₹402.86 | +100.0% | Revenue/Share: ₹2671.25, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹366.24 | ₹329.62 - ₹402.86 | +100.0% | EBITDA: ₹1964.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹457.80 | ₹366.24 - ₹549.36 | +150.0% | CF Growth: 10.4%, Discount: 15% |
| PEG Ratio Method | growth | ₹60.93 | ₹54.84 - ₹67.02 | -66.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹78.44 | ₹70.60 - ₹86.28 | -57.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹366.24 | ₹329.62 - ₹402.86 | +100.0% | ROE: 5.1%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹549.36 | ₹494.42 - ₹604.30 | +200.0% | EPS: ₹9.52, BVPS: ₹1711.56 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
JINDALSAW Intrinsic Value Analysis
What is the intrinsic value of JINDALSAW?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Jindal SAW (JINDALSAW) is ₹366.24 (median value). With the current market price of ₹183.12, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹60.93 to ₹549.36, indicating ₹60.93 - ₹549.36.
Is JINDALSAW undervalued or overvalued?
Based on our multi-method analysis, Jindal SAW (JINDALSAW) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.56 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 5.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.82x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Jindal SAW
Additional stock information and data for JINDALSAW
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2,335 Cr | ₹1,887 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2,593 Cr | ₹1,635 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1,616 Cr | ₹1,582 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹74 Cr | ₹-21 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹1,570 Cr | ₹1,390 Cr | Positive Free Cash Flow | 8/10 |